Product News

Share this article:

AstraZeneca's Seroquel XR picked up an indication for the treatment of acute depressive, manic, and mixed episodes of bipolar disorder. The drug is now available in two new tablet strengths: 50 mg and 150 mg.

Takeda's proton pump inhibitor Kapidex received FDA approval for the treatment of heartburn associated with symptomatic non-erosive Gastroesophageal Reflux Disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE. It is now available in US pharmacies in 30mg and 60mg doses.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters